Korean United Pharm. Inc. is a leading pharmaceutical manufacturer based in South Korea, recognized for its strong focus on research, development, and high-quality pharmaceutical production for global healthcare markets.
With decades of industry experience, the company has built a robust portfolio of finished dosage forms and active pharmaceutical ingredients, supported by advanced manufacturing capabilities and stringent quality systems.
Korean United Pharm. Inc. operates in compliance with international regulatory standards and actively supplies products to regulated and emerging markets, reinforcing its position as a trusted global pharmaceutical partner.
Founded in 1962, Laboratorios IMA is today the largest fully segregated oncology injectable manufacturing plant in Argentina. The company is a regional reference for the development and production of injectable oncology and onco-hematology pharmaceutical products, supplying more than 60% of the generic oncology injectables distributed in Argentina.
Acquired by Cristália, one of the top five pharmaceutical companies in Brazil, in 2011, Laboratorios IMA entered a strong growth phase, expanding its portfolio, research and development capabilities, and regional distribution reach. Today, IMA has a strong presence across Latin America, Asia, and selected international markets, supported by robust dossiers compliant with ICH standards (Zone IV-B).
Established in 1958, Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical companies in China, engaged in the development, manufacturing, and global distribution of high-quality Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs).
With a strong manufacturing and research foundation, Qilu operates 12 subsidiaries and 11 domestic manufacturing sites, supported by a global workforce of over 36,000 professionals. In 2024, Qilu ranked among the top three pharmaceutical companies in China, reflecting its scale and industry leadership.
JODAS is a global, specialty-driven pharmaceutical company focused on the development, manufacturing, and commercialization of high-quality generic formulations. Founded in 2008 in India, JODAS has rapidly established itself among emerging international pharmaceutical organizations.
Driven by research, innovation, and affordability, JODAS operates with a strong commitment to quality, offering specialty pharmaceutical products that address critical healthcare needs across global markets.
The company’s operations are centered on four key therapeutic segments, with a primary focus on injectable formulations for regulated and semi-regulated markets.
Hainan Poly Pharm Co.Ltd. is a leading pharmaceutical manufacturer in China, dedicated to the research, development, manufacturing, and global marketing of high-quality therapeutic products.
Established in 1992, the company has developed a diversified product portfolio covering both Active Pharmaceutical Ingredients (APIs) and finished dosage forms.
Kwality Pharmaceuticals Ltd., founded in 1983 and headquartered in Amritsar, India, is a leading manufacturer and exporter of high-quality finished pharmaceutical formulations for international markets. The company integrates comprehensive manufacturing capabilities with global regulatory compliance to deliver reliable medicines across multiple therapeutic categories.
With advanced facilities in Punjab and Himachal Pradesh, Kwality Pharma produces a broad portfolio of pharmaceutical products including liquid orals, tablets, capsules, sterile powders for injection, ophthalmic preparations, and specialized formulations such as beta-lactams, cephalosporins, oncology injectables, and biologics.
The company’s manufacturing plants operate under stringent quality management systems and have earned certifications such as WHO-GMP, ISO 9001:2015, and ISO 14001:2015, reflecting its commitment to safety, efficacy, and environmental stewardship. Kwality Pharma’s products are registered in regulated and emerging markets worldwide, underscoring its global presence and compliance excellence.
SP Accure Labs Pvt. Ltd. (SPAL) is a fully integrated, quality-driven pharmaceutical company dedicated to making high-quality medicines accessible to patients worldwide. With a strong focus on Oncology, SPAL is committed to improving lives through excellence at every stage of pharmaceutical development and manufacturing.
The company’s state-of-the-art production facility is strategically located in the biotechnology park at Hyderabad, India, supported by robust infrastructure, advanced manufacturing technology, and a comprehensive research and development center designed to deliver safe, reliable, and world-class pharmaceutical products.